Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03128307
Other study ID # Zyppah01
Secondary ID
Status Completed
Phase Phase 3
First received April 17, 2017
Last updated November 27, 2017
Start date April 7, 2017
Est. completion date August 10, 2017

Study information

Verified date November 2017
Source Zyppah, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Online patient registration to participate in clinical trial to test OTC mouthpiece that controls position of the tongue to reduce snoring.


Description:

Patient will complete informed consent, inclusion/exclusion criteria, sleep apnea and snoring surveys online. If patient meets all criteria for the study, patient will be provided with a treatment device for use for a 10 day treatment period. Patient will complete the trial upon providing final online surveys.


Recruitment information / eligibility

Status Completed
Enrollment 604
Est. completion date August 10, 2017
Est. primary completion date May 3, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Over 18 years of age

- Living in the United States

- Signing the Informed Consent Form

Exclusion Criteria:

- Missing teeth (as the device won't be properly fitted)

- Any severe breathing or respiratory disorder, such as chronic asthma, emphysema, COPD, or a similar condition

- Poor dental health, such as severe gum disease, loose teeth, an abscess, mouth sores, or bleeding gums

- A dental implant placed within the last three months

- Diagnosed with a Temporomandibular joint condition (TMJ)

- Actively experiencing any mouth or jaw pain, including clenching of the teeth, grinding, or any other physical injury to the jaw or teeth

- Full dentures

- Braces

- Diagnosis of sleep apnea

- Less than 18 years of age

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Zyppah Anti-snoring Appliance
Use of an OTC mouth guard at night to prevent snoring

Locations

Country Name City State
United States The EyeDeas Company Lake Forest California

Sponsors (1)

Lead Sponsor Collaborator
Zyppah, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Snoring Severity Scale The Snoring Severity Scale (SSS) is a 9-point, validated scale to measure the severity of snoring. A total of three questions are asked: 1) "How often do you snore, 2) "How long do you snore", and 3) How audible is your snoring. Answers for each of these questions are summed for a total SSS score. A score of '0' would indicate no snoring at all, while a score of '9' would indicate the most severe snoring as measured by the SSS.
Outcome measure reported as change with use of the device over pre-trial. In this case, a negative ('-') would represent improvement in snoring symptoms, while a positive ('+') number would indicate an increase in snoring severity.
Baseline and 10 Days
Primary Visual-Analogue Scale, Self-Reported Snoring Habits Quantitative assessment on 1-10 scale. Outcome measurement reported as a percentage change from pre-trial with use of the device. A negative ('-') percentage would indicate a reduction in snoring symptoms as measured by the VAS, while a positive percentage ('+') result would indicate an increase in the measured symptom. Baseline and 10 Days
See also
  Status Clinical Trial Phase
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Active, not recruiting NCT02470182 - Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors
Completed NCT03964324 - NO Measurements in Screening for Asthma and OSA, in Patients With Severe Snoring N/A
Completed NCT06186687 - Rehabilitative Approaches: Myofunctional Therapy and Retropalatal Narrowing and Snoring N/A
Completed NCT03333876 - In Home Assessment of Three Anti-Snoring Devices, a Cross Over Study N/A
Completed NCT03640793 - Prospective Evaluation of a Palato-Pharyngeal Implant System (PPIS) Obstructive Sleep Apnea Syndrome (OSAS) N/A
Not yet recruiting NCT04143022 - Evaluation of the Effects of Acupuncture Press Needle in Mild to Moderate Obstructive Sleep Apnea Patients N/A
Completed NCT02834767 - Genioglossus Muscle Training for Snoring and Obstructive Sleep Apnea N/A
Terminated NCT01772017 - A Trial to Evaluate a Device for the Treatment of OSA and Snoring N/A
Withdrawn NCT01680380 - Tracking Breathing During Sleep With Non-contact Sensors N/A
Unknown status NCT00806637 - Vessel Sealing System Uvulopalatoplasty Versus Uvulopalatal Flap N/A
Completed NCT00560859 - Childhood Adenotonsillectomy Study for Children With OSAS N/A
Terminated NCT03701165 - The Effect of the DryMouth Shield on Snoring N/A
Active, not recruiting NCT05643352 - Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring N/A
Recruiting NCT05756647 - Mandibular Advancement vs Home Treatment for Primary Snoring Phase 2
Completed NCT04086407 - Apnea Hypopnea Index Severity Versus Head Position During Sleep N/A
Not yet recruiting NCT05116657 - Obstructive Sleep Apnoea Post Covid 19: Role of the Upper Airway Microbiome
Completed NCT01491828 - Study to Determine Results of Vibratory Stimulus on Subject's Neck Phase 1
Completed NCT01322334 - Singing Exercises to Improve Symptoms of Snoring and Sleep Apnea N/A
Terminated NCT03316963 - Neostigmine For Snoring During DISE Early Phase 1